Zynlonta Patient - r/r DLBCL Treatment | ZYNLONTA® …
ZYNLONTA ® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or more treatments for their cancer. It is not known if ZYNLONTA ® is safe and effective in children.
Loncastuximab tesirine - Wikipedia
Loncastuximab tesirine, sold under the brand name Zynlonta, is a monoclonal antibody conjugate medication used to treat large B-cell lymphoma and high-grade B-cell lymphoma. [1] [2] It is an antibody-drug conjugate (ADC) composed of a humanized antibody targeting the protein CD19. [1]
R/R DLBCL Treatment | ZYNLONTA® (loncastuximab tesirine-lpyl) …
2022年4月1日 · ZYNLONTA ® is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low-grade lymphoma, and high-grade B-cell lymphoma.
Zynlonta: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年8月22日 · Zynlonta is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or more treatments for their cancer.
Zynlonta Patient Brochure
ZYNLONTA ® (loncastuximab tesirine-lypl) is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or …
Dosing | ZYNLONTA® (loncastuximab tesirine-lpyl) HCP Site
ZYNLONTA ® is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from …
What is ZYNLONTA? ZYNLONTA is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or more treatments for their cancer.
DailyMed - ZYNLONTA- loncastuximab tesirine injection, powder ...
2024年7月12日 · ZYNLONTA is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low-grade lymphoma, and high-grade B-cell lymphoma.
ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site - Zynlonta …
ZYNLONTA ® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or more treatments for their cancer. It is not known if ZYNLONTA ® is safe and effective in children.
Zynlonta - European Medicines Agency (EMA)
2023年1月26日 · Zynlonta is a medicine for treating two types of B-cell lymphoma (a type of blood cancer): diffuse large B-cell lymphoma (DLBCL); high-grade B-cell lymphoma (HGBL).